Mink Therapeutics Inc (INKT)

Jun 10, 2025

Where are the Opportunities in (INKT) - news.stocktradersdaily.com

Jun 10, 2025

Jun 10, 2025

Kalkine: MiNK Therapeutics Sees Gains Amid Positive Earnings Per Share Momentum - Kalkine Media

Jun 10, 2025

Jun 10, 2025

MiNK Therapeutics Announces Virtual Annual Shareholders Meeting - Eagle-Tribune

Jun 10, 2025

Jun 10, 2025

MiNK Therapeutics Annual Meeting: How Shareholders Can Join Virtually on June 18 - Stock Titan

Jun 10, 2025

Jun 10, 2025

MiNK Therapeutics (NASDAQ:INKT) Stock Price Up 0.1% – Here’s Why - Defense World

Jun 10, 2025

Jun 03, 2025

MiNK Therapeutics receives NIH grant for GvHD therapy - Investing.com India

Jun 03, 2025

Jun 02, 2025

MiNK Therapeutics, Inc. Awards Prestigious Niaid Grant to Advance Allo-Inkt Cell Therapy for Prevention of Gvhd in Stem Cell Transplant Patients - MarketScreener

Jun 02, 2025

Jun 02, 2025

INKT Secures Grant for GvHD Cell Therapy Development | INKT Stoc - GuruFocus

Jun 02, 2025

Jun 02, 2025

MiNK Therapeutics Receives NIAID Grant to Advance Allo-iNKT Cell Therapy for Graft-Versus-Host Disease Treatment - Nasdaq

Jun 02, 2025

Jun 02, 2025

MiNK Therapeutics Awarded Prestigious NIAID Grant to - GlobeNewswire

Jun 02, 2025

Jun 02, 2025

NIH Backs Revolutionary Cell Therapy: MiNK's Solution Could Prevent Deadly Transplant Complications - Stock Titan

Jun 02, 2025

May 29, 2025

(INKT) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com

May 29, 2025

May 28, 2025

Amer Sports: The New ONON and DECK of Consumer Discretionary? - The Globe and Mail

May 28, 2025

May 19, 2025

MiNK Therapeutics outlines near-term partnering proposals and reduced cash burn as company advances iNKT programs - MSN

May 19, 2025

May 19, 2025

HC Wainwright Cuts Earnings Estimates for MiNK Therapeutics - Defense World

May 19, 2025

May 16, 2025

MiNK Therapeutics, Inc. (NASDAQ:INKT) Q1 2025 Earnings Call Transcript - Insider Monkey

May 16, 2025

May 16, 2025

MiNK Therapeutics Reports Q1 2025 Progress and Financials - TipRanks

May 16, 2025

May 15, 2025

Mink Therapeutics’ Earnings Call Highlights Progress and Optimism - TipRanks

May 15, 2025

May 15, 2025

Transcript : MiNK Therapeutics, Inc., Q1 2025 Earnings Call, May 15, 2025 - marketscreener.com

May 15, 2025

May 15, 2025

MiNK Therapeutics (INKT) Advances in Immune Response Innovation - GuruFocus

May 15, 2025

May 15, 2025

MiNK Therapeutics (INKT) Advances in Immune Response Innovation | INKT Stock News - GuruFocus

May 15, 2025

May 15, 2025

MiNK Therapeutics Reports Clinical Advancements and Financial Update for Q1 2025, with Focus on iNKT Cell Therapies - Nasdaq

May 15, 2025

May 15, 2025

Palvella Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update - The Manila Times

May 15, 2025

May 15, 2025

MiNK Therapeutics Reports Q1 2025 Results and Highlights Clinical & Strategic Progress - GlobeNewswire

May 15, 2025

May 11, 2025

MiNK Therapeutics (INKT) Projected to Post Earnings on Tuesday - Defense World

May 11, 2025

May 09, 2025

Refractory Multiple Myeloma Pipeline Appears Robust With 75+ - openPR.com

May 09, 2025

May 08, 2025

How to Take Advantage of moves in (INKT) - news.stocktradersdaily.com

May 08, 2025

May 05, 2025

MiNK Therapeutics to Announce Q1 2025 Financial Results and Host Conference Call on May 15th - Nasdaq

May 05, 2025

May 05, 2025

MiNK Therapeutics to Provide Corporate Update and First Quarter 2025 Financial Report - GlobeNewswire

May 05, 2025

May 05, 2025

Geode Capital Management LLC Lowers Stock Position in MiNK Therapeutics, Inc. (NASDAQ:INKT) - Defense World

May 05, 2025

Apr 23, 2025

Learn to Evaluate (INKT) using the Charts - news.stocktradersdaily.com

Apr 23, 2025

Apr 19, 2025

Comparing Atyr PHARMA (NASDAQ:ATYR) and MiNK Therapeutics (NASDAQ:INKT) - Defense World

Apr 19, 2025

Apr 15, 2025

ImmunityBio Announces FDA Submissions of Supplemental BLA for NMIBC Papillary Disease and for Expanded Access of ANKTIVA® to Treat Lymphopenia - Business Wire

Apr 15, 2025

Apr 13, 2025

LIfT BioSciences appoints new CSO - Bdaily

Apr 13, 2025

Apr 07, 2025

LIfT BioSciences Appoints Mark A. Exley as Chief Scientific Officer - EIN News

Apr 07, 2025

Apr 07, 2025

ImmunityBio to Host Key Opinion Leader and Investor Meeting to Provide Updates on Clinical Programs and ANKTIVA Commercial Launch - Business Wire

Apr 07, 2025

Apr 06, 2025

(INKT) Trading Report - news.stocktradersdaily.com

Apr 06, 2025

Mar 30, 2025

Reviewing MiNK Therapeutics (NASDAQ:INKT) & Creative Medical Technology (NASDAQ:CELZ) - The AM Reporter

Mar 30, 2025

Mar 22, 2025

HC Wainwright Issues Negative Forecast for INKT Earnings - Defense World

Mar 22, 2025

Mar 22, 2025

What is William Blair’s Forecast for INKT Q1 Earnings? - Defense World

Mar 22, 2025

Mar 21, 2025

What is William Blair’s Estimate for INKT Q1 Earnings? - Defense World

Mar 21, 2025

Mar 19, 2025

MiNK Therapeutics, Inc. (NASDAQ:INKT) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 19, 2025

Mar 19, 2025

MiNK Therapeutics (NASDAQ:INKT) Given Buy Rating at HC Wainwright - Defense World

Mar 19, 2025

Mar 19, 2025

MiNK Therapeutics Inc (INKT) Q4 2024 Earnings Call Highlights: Strategic Advances Amid ... By GuruFocus - Investing.com Canada

Mar 19, 2025

Mar 18, 2025

MiNK Therapeutics Reports 2024 Progress and Financials - TipRanks

Mar 18, 2025

Mar 18, 2025

MiNK Therapeutics’ Earnings Call Highlights Strategic Gains - TipRanks

Mar 18, 2025

Mar 18, 2025

MiNK Therapeutics, Inc. SEC 10-K Report - TradingView

Mar 18, 2025

Mar 18, 2025

Earnings call transcript: Mink Therapeutics Q4 2024 reports reduced net loss - Investing.com

Mar 18, 2025

Mar 18, 2025

Mink Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 18, 2025

Mar 18, 2025

MiNK Therapeutics Reports Fourth Quarter & Full Year 2024 Results and Highlights Business Progress - GlobeNewswire

Mar 18, 2025

Mar 18, 2025

MiNK Therapeutics Reports 2024 Financial Results and Highlights Clinical Advancements in iNKT Cell Therapies - Nasdaq

Mar 18, 2025

Mar 18, 2025

MiNK Therapeutics reports Q4 EPS (62c), consensus (50c) - TipRanks

Mar 18, 2025

Mar 18, 2025

Earnings Scheduled For March 18, 2025 - Benzinga

Mar 18, 2025

Mar 17, 2025

AGENUS INC SEC 10-K Report - TradingView

Mar 17, 2025

Mar 17, 2025

(INKT) Technical Pivots with Risk Controls - Stock Traders Daily

Mar 17, 2025

Mar 14, 2025

Mink Therapeutics Inc expected to post a loss of 50 cents a shareEarnings Preview - TradingView

Mar 14, 2025